高VTA1表达是肺腺癌的不良预后因素
Xingang Sun1, Ruixin Wu2, Xinjun Guan3
1Department of Oncology, Huzhou Hospital of Traditional Chinese Medicine, Zhejiang University of Traditional Chinese Medicine, Huzhou 313000, China. dfr34568@163.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|February 19, 2024
概括
在非小细胞肺癌类型的肺腺癌 (LUAD) 中,VTA1的表达很高. 高VTA1表达表明预后不佳,并作为LUAD患者不良结果的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 肺腺癌 (LUAD) 是一种流行的非小细胞肺癌亚型.
- 确定可靠的生物标志物用于LUAD进展是一个关键的临床挑战.
- 尽管与其他癌症有关,但VTA1在LUAD中的作用尚未得到充分研究.
研究的目的:
- 为了研究VTA1在LUAD中的表达模式.
- 分析VTA1表达和LUAD患者的临床结果之间的相关性.
- 探索与LUAD中VTA1相关的分子机制和途径.
主要方法:
- 利用了来自癌症基因组图谱 (TCGA) 和基因型-组织表达 (GTEx) 项目的RNA测序数据.
- 进行了差异基因表达 (DEG) 分析,基因本体学 (GO) /基因和基因组的京都百科全书 (KEGG) 路径分析,基因组丰富分析 (GSEA) 和蛋白质-蛋白质相互作用 (PPI) 网络分析.
- 使用卡普兰-梅尔生存分析,考克斯回归和预后诺莫格拉姆模型评估临床意义.
主要成果:
- 与正常样本相比,LUAD组织中的VTA1显著上调.
- 高VTA1表达与先进的T,N,M阶段,病理阶段和残留瘤状态相关.
- 高VTA1表达是LUAD患者生存率低下的独立预后因素,与4232个差异表达基因相关.
结论:
- 过度表达VTA1是肺腺癌不良预后的潜在生物标志物.
- 已识别的DEG和途径为LUAD瘤发生和进展提供了洞察力.
- 对VTA1作用的进一步研究可能会导致针对LUAD的新型治疗策略.
更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


